Company Overview - Molina Healthcare has a market capitalization of $7.8 billion and provides managed healthcare services primarily to low-income families and individuals through Medicaid, Medicare, and state insurance marketplaces [2]. Recent Developments - In Q3 2025, Molina Healthcare reported adjusted earnings of $1.84 per share on premium revenue of $10.8 billion, which fell short of Wall Street expectations [4]. - The company recently reduced its full-year earnings guidance to $14 per share, down from an earlier forecast of $19 per share, and significantly lower than the initial projection of $24.50 per share at the start of 2025 [5]. Financial Performance - The disappointing Q3 results were attributed to rising medical costs and increased healthcare utilization, with the consolidated medical care ratio reaching 92.6% for the quarter [5]. - The Marketplace business, which constitutes 10% of total revenue, faced significant challenges, with its medical care ratio soaring to 95.6%. Management now anticipates a $2-per-share loss for the Marketplace segment, a drastic change from the previous expectation of over $3 per share in profits [6]. Medicaid Business - Despite challenges, the core Medicaid business, which accounts for 75% of premium revenue, continues to perform relatively well, with medical cost trends in Medicaid reaching 7% for the year, surpassing the negotiated rate increase of 5.5% with states [7]. Investment Activity - Notably, investor Michael Burry has taken a position in Molina Healthcare, acquiring 125,000 shares, which are currently down over 60% from their all-time highs [1].

Core Viewpoint - A lawsuit has been filed against Molina Healthcare, Inc. and certain senior executives for potential violations of federal securities laws, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [1][2]. Group 1: Lawsuit Details - Investors have until December 2, 2025, to request to lead the case, which is pending in the U.S. District Court for the Central District of California [2]. - The lawsuit is titled Hindlemann v. Molina Healthcare, Inc., et al., No. 25-cv-9461 [2]. Group 2: Company Background - Molina Healthcare is a health insurance company providing managed healthcare services to low-income individuals under Medicaid and Medicare programs [3]. - The company previously claimed a "solid" earnings growth profile heading into 2025 and stated it was monitoring utilization patterns to mitigate healthcare cost inflation [3]. Group 3: Financial Performance and Stock Impact - On July 7, 2025, Molina reported Q2 2025 adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines [4]. - The company cut its guidance for expected adjusted earnings per share by 10.2% to a range of $21.50 to $22.50 per share [4]. - Following further revelations on July 23, 2025, regarding full-year adjusted earnings expectations of no less than $19.00 per diluted share, Molina's stock price fell by $32.03, or 16.8%, from $190.25 to $158.22 per share [4].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Molina Healthcare, Inc. due to alleged violations of federal securities laws, encouraging investors who suffered losses exceeding $75,000 to contact them directly [1][3]. Summary by Sections Legal Investigation - The law firm is looking into claims against Molina Healthcare, highlighting a deadline of December 2, 2025, for investors to seek the role of lead plaintiff in a federal securities class action [1][6]. Allegations Against Molina - The complaint alleges that Molina and its executives made false or misleading statements regarding: 1. Material adverse facts about the company's medical cost trend assumptions [3]. 2. A dislocation between premium rates and medical cost trends [3]. 3. Molina's near-term growth being dependent on low utilization of various health services [3]. 4. A substantial likelihood of cutting financial guidance for fiscal year 2025 [3]. 5. Misleading positive statements about the company's business and prospects [3]. Financial Performance and Stock Impact - On July 7, 2025, Molina announced second-quarter financial results, revealing adjusted earnings of approximately $5.50 per share, which was below prior expectations, leading to a 10.2% cut in full-year earnings guidance from at least $24.50 to a range of $21.50 to $22.50 per share [4]. - Following this announcement, Molina's stock price fell by $6.97, or 2.9%, closing at $232.61 per share on July 7, 2025 [4]. - On July 23, 2025, Molina further slashed its full-year earnings guidance, reporting GAAP net income of $4.75 per diluted share for the second quarter, an 8% decrease year-over-year, and cutting full-year adjusted earnings guidance to no less than $19.00 per diluted share, representing a 13.6% cut [5]. - This led to a significant drop in Molina's stock price by $32.03, or 16.84%, closing at $158.22 per share on July 24, 2025 [5].

Core Viewpoint - A lawsuit has been filed against Molina Healthcare, Inc. and certain senior executives for potential violations of federal securities laws, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [1][2]. Group 1: Lawsuit Details - Investors have until December 2, 2025, to request to lead the case, which is pending in the U.S. District Court for the Central District of California [2]. - The lawsuit is titled Hindlemann v. Molina Healthcare, Inc., et al., No. 25-cv-9461 [2]. Group 2: Company Background - Molina Healthcare is a health insurance company providing managed healthcare services to low-income individuals under Medicaid and Medicare programs [3]. - The company previously claimed a "solid" earnings growth profile heading into 2025 and stated it was monitoring utilization patterns to mitigate healthcare cost inflation [3]. Group 3: Financial Performance and Stock Impact - On July 7, 2025, Molina reported Q2 2025 adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines [4]. - The company cut its guidance for expected adjusted earnings per share by 10.2% to a range of $21.50 to $22.50 per share [4]. - Following further revelations on July 23, 2025, Molina adjusted its full-year 2025 earnings expectation to no less than $19.00 per diluted share, citing a challenging medical cost trend environment [4]. - The stock price fell by $32.03 per share, or 16.8%, from $190.25 on July 23, 2025, to $158.22 on July 24, 2025, in response to these announcements [4].

Core Viewpoint - Molina Healthcare, Inc. is facing a class action lawsuit for alleged violations of the Securities Exchange Act of 1934, with claims related to undisclosed adverse financial conditions and misleading earnings guidance during the specified class period [1][4][5]. Company Summary - Molina Healthcare provides managed healthcare services primarily to low-income families and individuals through Medicaid, Medicare, and state insurance marketplaces [3]. - The company has been accused of failing to disclose critical information regarding its medical cost trend assumptions and the dislocation between premium rates and medical costs [4]. Financial Performance - On July 7, 2025, Molina Healthcare reported adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines [5]. - Following this announcement, the company's stock price experienced a decline, reflecting investor concerns over its financial outlook [5]. - On July 23, 2025, Molina Healthcare further cut its full-year 2025 earnings guidance, reporting a GAAP net income of $4.75 per diluted share for Q2 2025, an 8% decrease year-over-year, and projecting adjusted earnings of no less than $19.00 per diluted share for the full year [6]. - The stock price fell nearly 17% after this announcement, indicating significant market reaction to the revised earnings outlook [6]. Legal Proceedings - The class action lawsuit allows investors who purchased Molina Healthcare securities during the class period to seek appointment as lead plaintiff, representing the interests of all class members [7]. - Robbins Geller Rudman & Dowd LLP is the law firm leading the class action, which has a strong track record in securities fraud litigation [8].

Core Viewpoint - A lawsuit has been filed against Molina Healthcare, Inc. and certain senior executives for potential violations of federal securities laws, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [1][2]. Group 1: Lawsuit Details - Investors have until December 2, 2025, to request to lead the case, which is pending in the U.S. District Court for the Central District of California [2]. - The lawsuit is titled Hindlemann v. Molina Healthcare, Inc., et al., No. 25-cv-9461 [2]. Group 2: Company Background and Allegations - Molina Healthcare provides managed healthcare services to low-income individuals under Medicaid and Medicare programs [3]. - The company previously claimed a "solid" earnings growth profile heading into 2025 and stated it could mitigate healthcare cost inflation, which is now alleged to be untrue due to increased medical cost pressures [3]. Group 3: Stock Performance and Impact - On July 7, 2025, Molina reported Q2 2025 adjusted earnings of approximately $5.50 per share, which was below expectations due to medical cost pressures across all business lines [4]. - Following further announcements on July 23, 2025, regarding a challenging medical cost trend environment, Molina's stock price fell by $32.03 per share, or 16.8%, from $190.25 to $158.22 [4].

Core Viewpoint - A lawsuit has been filed against Molina Healthcare, Inc. and certain senior executives for potential violations of federal securities laws, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [1][2]. Group 1: Lawsuit Details - Investors have until December 2, 2025, to request to lead the case, which is pending in the U.S. District Court for the Central District of California [2]. - The lawsuit is titled Hindlemann v. Molina Healthcare, Inc., et al., No. 25-cv-9461 [2]. Group 2: Company Background - Molina Healthcare is a health insurance company providing managed healthcare services to low-income individuals under Medicaid and Medicare programs [3]. - The company previously claimed a "solid" earnings growth profile heading into 2025 and stated it was monitoring utilization patterns to mitigate healthcare cost inflation [3]. Group 3: Financial Performance and Stock Impact - On July 7, 2025, Molina reported Q2 2025 adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines [4]. - The company cut its guidance for expected adjusted earnings per share by 10.2%, revising it to a range of $21.50 to $22.50 per share [4]. - On July 23, 2025, Molina adjusted its full-year 2025 earnings expectation to no less than $19.00 per diluted share, citing a challenging medical cost trend environment [4]. - Following this announcement, Molina's stock price fell by $32.03 per share, or 16.8%, from $190.25 to $158.22 [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Molina Healthcare, Inc. securities between February 5, 2025, and July 23, 2025, of the December 2, 2025, deadline to become a lead plaintiff in a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Molina securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by December 2, 2025, to serve as lead plaintiff [2] - The lawsuit alleges that Molina failed to disclose several material adverse facts regarding its financial health and operational assumptions, which misled investors [4] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in this area [3] - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time, and has consistently ranked highly in securities class action settlements [3] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [3]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Molina Healthcare, Inc. due to allegations of violations of federal securities laws related to misleading statements and undisclosed adverse facts affecting the company's financial performance [4][6]. Summary by Sections Legal Investigation - Faruqi & Faruqi, LLP is encouraging investors who suffered losses in Molina to contact them regarding their legal options, particularly for those who purchased securities between February 5, 2025, and July 23, 2025 [1][4]. Allegations Against Molina - The complaint alleges that Molina and its executives made false or misleading statements and failed to disclose critical information, including: - Material adverse facts regarding the company's medical cost trend assumptions [6]. - A dislocation between premium rates and medical costs [6]. - Dependency on low utilization of various health services for near-term growth [6]. - Likelihood of a significant cut in financial guidance for fiscal year 2025 [6]. - Misleading positive statements about the company's business and prospects [6]. Financial Performance and Stock Impact - On July 7, 2025, Molina announced second-quarter financial results, revealing adjusted earnings of approximately $5.50 per share, which was below prior expectations, leading to a 10.2% cut in full-year earnings guidance from at least $24.50 to a range of $21.50 to $22.50 per share [7]. - Following this announcement, Molina's stock price fell by $6.97, or 2.9%, closing at $232.61 per share on July 7, 2025 [7]. - On July 23, 2025, Molina further reduced its full-year earnings guidance, reporting GAAP net income of $4.75 per diluted share for the second quarter, an 8% decrease year-over-year, and cutting its full-year adjusted earnings expectation to no less than $19.00 per diluted share, representing a 13.6% reduction [8][9]. - This led to a significant drop in Molina's stock price by $32.03, or 16.84%, closing at $158.22 per share on July 24, 2025 [9].

Core Points - Class action lawsuits have been filed on behalf of shareholders of several publicly-traded companies, with specific deadlines for filing lead plaintiff motions [1] RCI Hospitality Holdings, Inc. (NASDAQ: RICK) - Class period is from December 15, 2021, to September 16, 2025, with a lead plaintiff deadline of November 20, 2025 [2] - Allegations include materially false and misleading statements regarding tax fraud and bribery, which resulted in an understatement of legal risks and misleading positive statements about the company's business [2] Fortinet, Inc. (NASDAQ: FTNT) - Class period is from November 8, 2024, to August 6, 2025, with a lead plaintiff deadline of November 21, 2025 [3] - Allegations include misleading statements about the refresh cycle of products, lack of clarity on upgradeable firewalls, and misrepresentation of the refresh momentum, leading to materially misleading positive statements about the company's prospects [3] Molina Healthcare, Inc. (NYSE: MOH) - Class period is from February 5, 2025, to July 23, 2025, with a lead plaintiff deadline of December 2, 2025 [4] - Allegations include failure to disclose adverse facts regarding medical cost trend assumptions, dependency on low utilization of services for growth, and the likelihood of cutting financial guidance for fiscal year 2025, resulting in materially misleading positive statements about the company's operations [4]